Guha Udayan bought NXTC

January 30, 2026 · Form 4 insider transaction

Guha Udayan bought 14,670 shares of NextCure, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
14,670
Price
$0.00
Total value
N/A
RoleOfficer
SecurityEmployee Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 3, 2026
Shares owned after14,670
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

One fourth of the option vests on January 30, 2027. The remainder vests in 36 monthly installments beginning on February 28, 2027.

View the original Form 4 on SEC EDGAR